Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MAT2A |
| Upstream (Parents) |
|---|
| (<<) ACTB → MAT2A |
| (<<) DAZAP2 → MAT2A |
| (<<) DHX9 → MAT2A |
| (<<) HSPA8 → MAT2A |
| (<<) KCTD5 → MAT2A |
| (<<) MCL1 → MAT2A |
| (<<) PPIB → MAT2A |
| (<<) PRPF4B → MAT2A |
| (<<) PTPN11 → MAT2A |
| (<<) RAB5A → MAT2A |
| (<<) RAB5B → MAT2A |
| (<<) UBE2N → MAT2A |
| (<<) YWHAE → MAT2A |
| (<<) YWHAH → MAT2A |
| Downstream (Children) |
|---|
| MAT2A → ADAM15 (>>) |
| MAT2A → ADAM9 (>>) |
| MAT2A → ALDOA (>>) |
| MAT2A → ANKDD1A (>>) |
| MAT2A → B3GNT2 (>>) |
| MAT2A → BCL6 (>>) |
| MAT2A → BZW1 (>>) |
| MAT2A → CAT (>>) |
| MAT2A → CDK8 (>>) |
| MAT2A → CRKL (>>) |
| MAT2A → CSNK1A1 (>>) |
| MAT2A → EIF2AK2 (>>) |
| MAT2A → ELOVL1 (>>) |
| MAT2A → EZR (>>) |
| MAT2A → GNB5 (>>) |
| MAT2A → HMGCS1 (>>) |
| MAT2A → HSPA5 (>>) |
| MAT2A → HSPA9 (>>) |
| MAT2A → KPNA1 (>>) |
| MAT2A → MEX3D (>>) |
| MAT2A → MLX (>>) |
| MAT2A → NFKBIA (>>) |
| MAT2A → NOTCH2 (>>) |
| MAT2A → PAK2 (>>) |
| MAT2A → PIK3R3 (>>) |
| MAT2A → PPIF (>>) |
| MAT2A → PPP1CA (>>) |
| MAT2A → PPP1R3B (>>) |
| MAT2A → RAC3 (>>) |
| MAT2A → RHOB (>>) |
| MAT2A → ROCK2 (>>) |
| MAT2A → RPS14 (>>) |
| MAT2A → RYK (>>) |
| MAT2A → SH3KBP1 (>>) |
| MAT2A → SPATA2L (>>) |
| MAT2A → STK11 (>>) |
| MAT2A → STK4 (>>) |
| MAT2A → STX12 (>>) |
| MAT2A → TRIB1 (>>) |
| MAT2A → VAV3 (>>) |
| MAT2A → YRDC (>>) |
| MAT2A → YWHAZ (>>) |
